Walmart, Alibaba, Moderna, and More to Watch This Week
Home Depot, Lucid, TJX, and others also report earnings. Investors will see Fed minutes and economic data on manufacturing, home…
Echtzeit-Aktienkurs Moderna Inc.
Bid:
Ask:
Nachrichten zur Moderna Inc. Aktie
US Says Government, Not Moderna, Should Face COVID-19 Vaccine Lawsuit
US Says Government, Not Moderna, Should Face COVID-19 Vaccine Lawsuit
…
Moderna fallen nach Studiendaten: Zinssorgen belasten US-Börsen
Die Inflationssorgen lassen die Anleger an der Wall Street zum Wochenschluss nicht los. Der Dow wird unter anderem vom Pharmakonzern…
Moderna Inc. stock underperforms Friday when compared to competitors
Moderna Inc. stock underperforms Friday when compared to competitors...…
Stocks making the biggest moves midday: Deere, Airbnb, AutoNation, Moderna and more
Deere shares popped on strong earnings....…
Moderna Omicron booster cleared in Canada for children and adolescents
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Moderna: Health Canada Authorizes Omicron-Targeting Vaccine in 6-to-17-Year-Olds
Moderna: Health Canada Authorizes Omicron-Targeting Vaccine in 6-to-17-Year-Olds...…
Dow Jones, S&P 500, Nasdaq: Inflationssorgen lasten auf US-Börsen – Moderna-Aktie gerät unter Druck
Die Experten von Goldman Sachs erwarten mittlerweile sogar drei weitere Zinsschritte in den USA. Die wichtigsten Indizes liegen zunächst im…
Moderna: Die Pipeline verbessert sich - Kaufen! Aktienanalyse
New York (www.aktiencheck.de) - Moderna-Aktienanalyse von Jefferies & Co:
Die Analysten von Jefferies & Co stufen die Aktie von Moderna Inc.…
Moderna: Daten zum Grippeimpfstoff-Kandidaten fallen gemischt aus - Aktienanalyse
Kulmbach (www.aktiencheck.de) - Moderna-Aktienanalyse von "Der Aktionär":
Marion Schlegel vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Moderna Inc. (ISIN: US60770K1079,…
Moderna Stock Falls as Study of Flu Vaccine Has Mixed Results
The shot got a strong immune response, but wasn't shown to be more effective than other vaccines....…
Coronavirus tally: Moderna flu vaccine trial falls short on one goal, sending stock down
Moderna Inc. stock was down 6.6% premarket Friday, after the COVID vaccine maker said a trial of a flu…
BioNTech-Konkurrent Moderna: Nur gemischte Daten bei Grippe-Impfstoff – Aktie unter Druck
Das US-Biotech-Unternehmen Moderna hat am Donnerstag nur gemischte Daten zu seinem Grippeimpfstoff-Kandidaten mRNA-1010 vorgelegt. Dies berichtet die Nachrichtenagentur Bloomberg....…
Moderna Buy
NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat die Einstufung für Moderna nach Studiendaten zum Influenza-Impfstoff mRNA-1010 auf…
Moderna stock falls on mixed results of flu vaccine mRNA-1010 in phase 3 trial
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
DoorDash, DraftKings, Moderna, Redfin, and More Stock Market Movers
Fourth-quarter revenue at DoorDash rises 40%, and DraftKings boosts its guidance for fiscal 2023....…
Stocks to Watch: iBio, DoorDash, DraftKings, Moderna
Stocks to Watch: iBio, DoorDash, DraftKings, Moderna...…
After-Hours Alert: Why Moderna Stock Is Diving
Moderna Inc (NASDAQ: MRNA) shares are trading lower in Thursday's after-hours session after the company released interim Phase 3 safety and…
UPDATE 1-Moderna flu vaccine delivers mixed results in trial, shares fall
... Erman
Feb 16 (Reuters) - Moderna Inc on Thursday said
its closely......…
Moderna Shares Fall 5.9% on Mixed Results From Flu Shot Study
Moderna Shares Fall 5.9% on Mixed Results From Flu Shot Study...…
Moderna Flu Shot Gives Mixed Immune Results in Final-Stage Trial
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…
Moderna stock falls 5% after flu vaccine study results
Moderna Inc. shares dove more than 5% in after-hours trading Thursday, after the company announced that a study into a…
Moderna flu vaccine delivers mixed results in trial
...By Patrick Wingrove and Michael Erman
(Reuters) - Moderna Inc......…
Moderna, Inc.: Moderna Announces Interim Phase 3 Safety and Immunogenicity Results for mRNA-1010, a Seasonal Influenza Vaccine Candidate
mRNA-1010 demonstrated superiority on seroconversion rates for A/H3N2 and A/H1N1, superiority on geometric mean titer ratios for A/H3N2, and non-inferiority…
Pfizer/ BioNTech, Moderna set for 2024 trial in COVID vaccine patent dispute
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Moderna’s COVID vaccine will remain free for all Americans in coup for Bernie Sanders
Moderna Inc. will keep its COVID-19 vaccine available and free of charge for all people in the U.S. even after…
Coronavirus tally: Moderna promises to keep COVID vaccine available and free for all Americans
Moderna Inc. will keep its COVID-19 vaccines available and free for all people in the U.S. after the public-health…
Moderna CEO to testify in senate on proposed vaccine price hike
...(Reuters) - Senator Bernie Sanders said on Wednesday Moderna......…
Moderna Inc. stock outperforms market on strong trading day
Moderna Inc. stock outperforms market on strong trading day...…
Moderna promises to keep COVID vaccine free
Moderna Inc. MRNA said Tuesday it will keep its COVID-19 vaccines available and free for all people in the U.S.…
Moderna CEO to face Senate hearing over pricing for COVID shot
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Moderna CEO Stephane Bancel will testify before Senate next month on Covid vaccine price hike
Um den gesamten Artikel unter cnbc.com zu lesen, klicken Sie bitte auf die Überschrift...…
Federal government, not Moderna, should face COVID vaccine patent lawsuit, DoJ says
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
U.S. backs Moderna, says government should face COVID-19 vaccine lawsuit
...By Blake Brittain
(Reuters) - The U.S. government should face......…
Moderna to offer free COVID shots even after pandemic emergency
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Moderna Inc. stock outperforms competitors on strong trading day
Moderna Inc. stock outperforms competitors on strong trading day...…
Moderna (MRNA) Outpaces Stock Market Gains: What You Should Know
Moderna (MRNA) closed the most recent trading day at $171.48, moving +1.3% from the previous trading session....…
Insiderhandel: President verkauft Aktien von Moderna im Wert von 40.156$
Hoge, Stephen - Vorstand - Tag der Transaktion: 2023-02-10...…
Moderna Inc. stock rises Monday, still underperforms market
Moderna Inc. stock rises Monday, still underperforms market...…
Moderna, Cirrus Logic And Other Balance Sheet Powerhouses
These U.S. companies with market caps of at least $5 billion have earnings of at least 20 cents a share…
Insiderhandel: Aufsichtsrat verkauft Aktien von Moderna im Wert von 3.356.761$
Afeyan, Noubar - Aufsichtsrat - Tag der Transaktion: 2023-02-08...…
Fact Check-Moderna CEO did not say company made 100,000 COVID-19 vaccine doses before the pandemic started
...By Reuters Fact Check
At Davos 2023, Moderna CEO Stephane Bancel.../pfbid02TsXTLtfZfs4kB4o4KWjwbYHtKJ4YQzNXZEUFgJxXxhqdwiMmBYY5FywYwP1eTRUnl).
…
Moderna Inc. stock outperforms market on strong trading day
Moderna Inc. stock outperforms market on strong trading day...…
Corona-Impfstoffe von BioNTech und Moderna: Das ändert sich bald in den USA – die Folgen
Deutschland, die USA und viele Länder haben im Zuge der Corona-Pandemie Hunderte Millionen Impfdosen für ihre Länder bestellt. Nun will…
Bivalent COVID Vaccines Perform Worse Against Variant Now Dominant In United States: Studies
Bivalent COVID Vaccines Perform Worse Against Variant Now Dominant In United States: Studies
…
Moderna, Inc. (MRNA) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Moderna (MRNA) quite a bit. Thus, it is worth knowing the facts that could…
What Fauci Knew About Vaccine Ineffectiveness... And When
What Fauci Knew About Vaccine Ineffectiveness... And When
Authored…
Moderna (MRNA) Gains But Lags Market: What You Should Know
Moderna (MRNA) closed the most recent trading day at $171.06, moving +0.46% from the previous trading session....…
Moderna Inc. stock rises Tuesday, still underperforms market
Moderna Inc. stock rises Tuesday, still underperforms market...…
Carisma Therapeutics Appoints Moderna CSO of External Research Ventures, Lin Guey, to Scientific Advisory Board
PHILADELPHIA, Feb. 7, 2023 /PRNewswire/ -- Carisma Therapeutics Inc., a clinical stage biopharmaceutical company focused on discovering and developing innovative…